Quick Answer
BioCardia, Inc. reported Net Income of -$8.23 million for fiscal year 2025.
BioCardia, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$8.23M | -3.5% |
| 2024 | -$7.95M | +31.3% |
| 2023 | -$11.57M | +2.8% |
| 2022 | -$11.91M | +5.7% |
| 2021 | -$12.62M | +15.9% |
| 2020 | -$15.00M | -2.0% |
| 2019 | -$14.71M | -5.2% |
| 2018 | -$13.99M | -13.6% |
| 2017 | -$12.31M | -19.4% |
| 2016 | -$10.31M | -53.9% |
| 2015 | -$6.70M | -2962.0% |
| 2014 | $234.0K | +1131.6% |
| 2013 | $19.0K | -93.8% |
| 2012 | $305.0K | -96.8% |
| 2011 | $9.66M | +184.0% |
| 2010 | -$11.51M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.48M | +14.6% | +27.6% |
| June 30, 2025 | -$2.05M | -24.5% | +24.4% |
| March 31, 2025 | -$2.71M | -19.6% | -56.1% |
| September 30, 2024 | -$1.74M | +32.5% | -5.5% |
| June 30, 2024 | -$1.65M | +51.9% | +27.4% |
| March 31, 2024 | -$2.27M | +35.2% | +11.9% |
| September 30, 2023 | -$2.57M | +15.8% | +24.8% |
| June 30, 2023 | -$3.42M | -37.1% | +2.2% |
- BioCardia, Inc. showed a decrease of -3.5% in Net Income compared to the prior fiscal year.
- Over the 2010–2025 period, BioCardia, Inc.’s net income has grown by 28.5% (from -$11.51 million to -$8.23 million).
- The most recent figure is from BioCardia, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: